The content of this website has been produced in line with the SUTENT® (sunitinib malate) Summary of Product Characteristics for Great Britain.
SUTENT® (sunitinib malate) Prescribing Information for Great Britain click here 12.5mg, 25mg, 50mg. SUTENT® (sunitinib malate) Prescribing Information for Northern Ireland click here. Adverse event reporting information can be found at the bottom of the page.
If this material is shared with patients it must be downloaded and NOT shown directly to patients from this website, which is intended for UK Health Professionals only.
Check back soon to see if new materials have been added, or try looking for another brand or therapy area.
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021